視頻：Microlife專利AFIB心房纖顫偵測技術

Microlife專利AFIB心房纖顫偵測技術

  • Microlife的<strong>專利AFIB</strong>心房纖顫偵測技術

    在家中測量血壓時最可靠的心房顫動 (AFIB) 檢測
心房纖顫(AFIB)是其中一種最常見的心律不正疾病

Microlife的專利AFIB心房纖顫偵測技術

心房顫動是最致命的一種心律不整現象

心房纖顫(AFIB)是其中一種最常見的心律不正疾病，通常是亳無症狀的，也難以被診斷出來，但卻是導致中風的其中一個重要成因。Microlife研發出在MAM模式測量血壓期間，能偵測無症狀的心房纖顫的全球首創專利心房纖顫(AFIB)偵測技術，靈敏度高達98%。

Microlife的心房纖顫偵測技術是如何運作?

市面上大部分血壓計只能偵測不規則性心跳和心律不正的症狀。 然而，這未能區分不同類型的心律失常。

Microlife成功研究出AFIB技術，在與醫生合作研發下將先進的演算法植入到血壓計內，能在家中血壓測量期間同時偵測心房纖顫。 在測量血壓的過程中，如偵測到心房纖顫，將會顯示橢圓形的心房纖顫AFIB圖樣在血壓計的屏幕上，為您提供重要的信息。若有懷疑，建議你向醫生查詢，並進行心電圖 (ECG) 檢查來確認心房纖顫的存在。

Microlife AFIB技術經過多項嚴格的臨床試驗，它的高精準度受到世界各地的廣泛認可。[1] 臨床試驗證實AFIB技術的靈敏度高達98%，且結果顯示其準確性高達89%。

準確專注篩檢心房顫動

臨床證實Microlife的心房顫動偵測具有高度敏感性(98%)與高度特異性(92%)

  • 臨床研究累計超過 10,000 名樣本，並發表於國際知名期刊。

    臨床研究累計超過 10,000 名樣本，並發表於國際知名期刊。

  • 經臨床實證，在基礎醫療及居家量測血壓，同時偵測心房顫動，可作為 AF 初篩的可靠工具。

    經臨床實證，在基礎醫療及居家量測血壓，同時偵測心房顫動，可作為 AF 初篩的可靠工具。
<strong>獲英國國家醫療標凖機構 (Nice) 推薦</strong>

獲英國國家醫療標凖機構 (Nice) 推薦

醫師專業推薦 ： No.1 的心房顫動偵測技術！

Microlife 心房顫動偵測技術，有助於早期準確檢測心房纖顫以預防中風。 英國國家醫療標凖機構 (Nice) 正式建議所有全科醫生在常規血壓測量期間，以內置心房纖顫(AFIB)偵測技術的Microlife醫學專業級的血壓計WatchBP Home A為病人測量。 [2]

  • “The available evidence suggests that the device reliably detects atrial fibrillation and may increase the rate of detection when used in primary care.”
  • “WatchBP Home A should be considered for use in people with suspected hypertension and those being screened or monitored for hypertension, in primary care.”
  • Prevention of 2,000 strokes per year in the UK (81 per 100,000 patients screened aged 65 - 75 years and 182 per 100,000 patients aged 75 years and older).
  • Healthcare cost savings of € 31 million a year.

參考文章:1. Verberk WJ, Omboni S, Kollias A, Stergiou GS: Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 2016; 203:465-473.2. NICE: WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension http://guidance.nice.org.uk/MTG13. 2013; Assessed 18 Aug. 2015.3. AFIB technology[EB/OL]. https://www.microlife.com/technologies/blood-pressure/afib-technology.

國際臨床實證列表

  • 國際臨床實證列表

心房顫動 AFIB 偵測專利技術相關產品

2013 Oxford Trail牛津臨床試驗

著名的英國牛津大學在2013年，針對1,000名家醫科患者進行了一項隨機臨床試驗 ，研究結果表明:

百略醫學的AFIB對於心房顫動的初步篩檢來說是最好的選擇，量血壓同時量測，操作簡單不需專業解釋，且準確度可媲美診間使用的單導ECG。

「所以在基層醫療與居家使用上，Microlife AFIB比ECG更適合做為房顫的篩檢工具。這些資料建議使用心房顫動技術進行居家血壓量測，有優異的診斷準確度，因此於初期診斷時可用來作為可靠的篩檢試驗。 」- Dr. George S. Stergiou（（ESH成員，歐洲著名高血壓專家，已發表5本著作＆超過１５０篇相關研究）

國內外參考文獻

    • Nichols M TN, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis 2012.
    • Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH et al.: Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 2015; 128:509-518 e502.
    • Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S: Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6:213-220.
    • Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al.: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478-2486.
    • Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J et al.: Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370:2467-2477.
    • Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385-1413.
    • Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131:492-501.
    • Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al.: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383:955-962.
    • Verberk WJ, Omboni S, Kollias A, Stergiou GS: Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 2016; 203:465-473.
    • Wiesel J, Wiesel D, Suri R, Messineo FC: The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol 2004; 27:639-643.
    • Wiesel J, Wiesel D, Suri R, Messineo FC: The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol 2004; 27:639-643.
    • Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M: Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009; 23:654-658.
    • Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
    • Wiesel J, Abraham S, Messineo FC: Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013; 111:1598-1601.
    • Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D, Hobbs FR et al.: Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
    • Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.
    • Gandolfo C, Balestrino M, Bruno C, Finocchi C, Reale N: Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci 2015; 36:1675-1678.
    • Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Circulation 2017; 135:110-112.
    • Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. BMJ Open 2017; 7:e013685.
    • Alpert BS, Quinn D, Gallick D: Oscillometric blood pressure: a review for clinicians. J Am Soc Hypertens 2014; 8:930-938.
    • NICE: WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension http://guidance.nice.org.uk/MTG13. 2013; Assessed 18 Aug. 2015.